Operating Lease, Liability of EAGLE PHARMACEUTICALS, INC. from 31 Dec 2019 to 30 Jun 2023
- Taxonomy & unit
- us-gaap: USD
- Description
- Present value of lessee's discounted obligation for lease payments from operating lease.
- Summary
-
EAGLE PHARMACEUTICALS, INC. quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2019 to 30 Jun 2023.
- EAGLE PHARMACEUTICALS, INC. Operating Lease, Liability for the quarter ending 30 Jun 2023 was $2,261,000, a 39% decline year-over-year.
- Source SEC data
- View on sec.gov
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)
EAGLE PHARMACEUTICALS, INC. Quarterly Operating Lease, Liability (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $2,261,000 | -$1,471,000 | -39% | 30 Jun 2023 | 10-Q/A | 09 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $2,642,000 | -$1,258,000 | -32% | 31 Mar 2023 | 10-Q | 09 May 2023 | 2023 | Q1 |
| Q4 2022 | $3,042,000 | -$1,171,000 | -28% | 31 Dec 2022 | 10-K | 23 Mar 2023 | 2022 | FY |
| Q3 2022 | $3,382,000 | -$865,000 | -20% | 30 Sep 2022 | 10-Q | 09 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $3,732,000 | -$802,000 | -18% | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $3,900,000 | -$912,000 | -19% | 31 Mar 2022 | 10-Q | 09 May 2022 | 2022 | Q1 |
| Q4 2021 | $4,213,000 | -$869,000 | -17% | 31 Dec 2021 | 10-K | 08 Mar 2022 | 2021 | FY |
| Q3 2021 | $4,247,000 | +$285,000 | +7.2% | 30 Sep 2021 | 10-Q | 09 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $4,534,000 | 30 Jun 2021 | 10-Q | 09 Aug 2021 | 2021 | Q2 | ||
| Q1 2021 | $4,812,000 | 31 Mar 2021 | 10-Q | 10 May 2021 | 2021 | Q1 | ||
| Q4 2020 | $5,082,000 | +$981,000 | +24% | 31 Dec 2020 | 10-K | 05 Mar 2021 | 2020 | FY |
| Q3 2020 | $3,962,000 | 30 Sep 2020 | 10-Q | 02 Nov 2020 | 2020 | Q3 | ||
| Q4 2019 | $4,101,000 | 31 Dec 2019 | 10-Q | 02 Nov 2020 | 2020 | Q3 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.